|
0730-0900
|
|
HT-01: Hot Topic: Managing Synchronous Urological Conditions – Can there be a Consensus
Room: Rumeli LL3
Co-Chairs: Prem Kumar, India / Bhavan Rai, United Kingdom
|
|
0730-0740
|
|
What is the Optimal Surgical Strategy in a Patient With Ipsilateral 1.5 cm Renal Calculus and 4 cm Small Renal Mass?
Muddassar Hussain, United Kingdom
|
|
0740-0750
|
|
Managing a 5 cms Bladder Stone and 90 gm Prostate in Men with Urinary Retention
Henry Woo, Australia
|
|
0750-0800
|
|
Management of Synchronous High-grade Unilateral UTUC in the Renal Pelvis and Recurrent Low-grade NMIBC in a Fit Patient
Benjamin Pradere, France
|
|
0800-0810
|
|
Bilateral Giant Hydronephrotic Kidney in a Child - How to Manage
Prem Kumar, India
|
|
0810-0820
|
|
Considerations in the Management of Synchronous Bilateral Renal Masses
Zeeshan Aslam, United Kingdom
|
|
0820-0830
|
|
Diagnostic and Management Strategy in a Fit Patient With CIS Bladder and High-risk Prostate Cancer With Pelvic and Retroperitoneal Lymphadenopathy
Theodoros Tokas, Greece
|
|
0830-0900
|
|
Discussion and Expert Comments
|
|
|
0730-0900
|
|
HT-02: Hot Topic: Simulation in Learning Urology – Is it the Future!
Room: Rumeli LL12
Co-Chairs: Ashish Rawandale-Patil, India / Gokul Vignesh KandaSwamy, United Kingdom
|
|
|
|
0730-0900
|
|
IC-01: Instructional Course: Scientific Writing Course
Room: Rumeli LL7
Chair: Cosimo de Nunzio, Italy
|
|
The course is intended for residents and young urologists who want to learn or improve their scientific writing skills and their ability in interpreting a scientific paper. The objective of the course is to provide some tips and ticks on how to write a scientific manuscript and to better present your results and reply to the reviewers ‘comments. During the course we will comment and analyze different scientific papers and will give an overview of the bibliometric indexes and of the peer review process. We will focus on different articles submitted to Prostate Cancer and Prostatic diseases and SIU journal.
Learning Objectives:
At the end of this session, attendees should be able to:
- Perform a medline on a specific topic using pubmed, embase and scopus.
- Understand the basics of scientific writing.
- Understand the different bibliometric indexes.
- Understand the different phases of peer-review process.
|
|
|
|
0730-0900
|
|
IS-01: Interactive Session: Global Youth Forum - There’s Life Beyond Clinical Urology
Room: Rumeli LL1
Co-Chairs: Gabriela Caballero, Mexico / Belthangady Monu Zeeshan Hameed, India
|
|
|
|
0730-0900
|
|
IS-02: Interactive Session: Leadership in Urology
Room: Rumeli LL4
Co-Chairs: Franck Bladou, France / Jay Shah, United States
|
|
0730-0740
|
|
Developing Leadership Skills for Urologists
Anurag Golash, United Kingdom
|
|
0740-0750
|
|
How to be Fair and Ethical as a Leader
|
|
0750-0800
|
|
Leading Change and Innovation in Urology
Arun Chawla, India
|
|
0800-0810
|
|
The Role of Leaders in Promoting Diversity and Inclusion in Urology
|
|
0810-0820
|
|
Developing Future Leaders in Urology
Xingang Cui, China
|
|
0820-0830
|
|
The Impact of Leadership on Patient Care and Outcomes in Urology
Jahangir Kabir, Bangladesh
|
|
0830-0900
|
|
Discussion
|
|
|
0730-0900
|
|
IS-03: Interactive Session: Setting up a Research Programme in Urology
Room: Rumeli LL9
Co-Chairs: Ranan Dasgupta, United Kingdom / Apul Goel, India
|
|
Learning Objectives:
At the end of this session, attendees should be able to:
- Understand as to how to build a research team.
- Understand the basics of machine learning analysis.
- Understand the types of study designs based on the research question.
- Understand the steps of doing a systematic review.
- Steps for encouraging urological research, at individual level and at institutional level.
- Understanding ethical challenges in research.
|
|
|
|
0730-0900
|
|
MC-01: Master Class: Visualizing Urological Complexities
Room: Rumeli LL2
Co-Chairs: Edgar Paez, United Kingdom / Rajan Veeratterapillay, United Kingdom
|
|
Learning Objectives
At the end of this session, attendees should be able to:
- Learn the intricacies of transperineal prostate biopsy
- Effectively apply MRI in management of bladder malignancy
- Learn the tips and tricks of augmented reality in renal tumors
- Understand the latest modalities adjunct to robotic surgeries
- Understand the planning of management of complex stone
|
|
|
|
0730-0930
|
|
SURG-01: Surgery Day - Screen One - Session 1
Room: Anadolu Oditoryum
Chair: Jean de la Rosette, Türkiye
Committee Members: Mélanie Aubé-Peterkin, Canada / Mevlana Derya Balbay, Türkiye / Mihir Desai, United States / Paolo Gontero, Italy / Stavros Gravas, Cyprus / Sung Kyu Hong, South Korea
|
|
Learning Objectives:
At the end of this course, participants should be able to:
- Update their knowledge of recent developments in equipment and technique for the minimally invasive and surgical management of urological diseases, based on live and pre-recorded surgical demonstrations.
- Acknowledge the role of open, laparoscopic, and robotic-assisted surgical procedures in uro-oncology and reconstructive urology, with respect to new systems, instrumentation, and techniques.
- Summarize practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions.
- Recognize the role of focal therapy and novel imaging approaches in uro-oncology.
- Recall perioperative considerations for optimizing urological surgery outcomes, based treatment guidelines and expert opinion.
|
|
|
|
0730-0930
|
|
SURG-02: Surgery Day - Screen Two - Session 1
Room: Anadolu Oditoryum
Co-Chair: Jean de la Rosette, Türkiye
Committee Members: Mélanie Aubé-Peterkin, Canada / Mevlana Derya Balbay, Türkiye / Mihir Desai, United States / Paolo Gontero, Italy / Stavros Gravas, Cyprus / Sung Kyu Hong, South Korea
|
|
Learning Objectives:
At the end of this course, participants should be able to:
- Update their knowledge of recent developments in equipment and technique for the minimally invasive and surgical management of urological diseases, based on live and pre-recorded surgical demonstrations.
- Acknowledge the role of open, laparoscopic, and robotic-assisted surgical procedures in uro-oncology and reconstructive urology, with respect to new systems, instrumentation, and techniques.
- Summarize practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions.
- Recognize the role of focal therapy and novel imaging approaches in uro-oncology.
- Recall perioperative considerations for optimizing urological surgery outcomes, based treatment guidelines and expert opinion.
|
|
|
|
0900-1030
|
|
PL-01: Plenary 01
Room: Rumeli Ballroom B2
Honorary Co-Chairs: Seth Lerner, United States / Rajeev T P, India / Li-Ping Xie, People's Republic of China
|
|
0900-0905
|
|
Welcome
|
|
0905-0910
|
|
Introduction to SIU-Mostafa M. Elhilali Award Lecture
|
|
0910-0925
|
|
SIU - Mostafa M. Elhilali Award Lecture: Building Future Leaders in Urology
|
|
0925-0940
|
|
Turkish Association of Urology (TAU) Lecture: New Trends in Robotic-assisted Retroperitoneal Partial Nephrectomy: Techniques and Outcomes
Mutlu Ateş, Türkiye
|
|
0940-0955
|
|
Pan African Urological Surgeons Association (PAUSA) Lecture: Progress in Minimally Invasive Urologic Surgery in Sub Saharan Africa: How to bridge the gap ?
Papa Ahmed Fall, Senegal
Learning Objectives:
At the end of this lecture, attendees should be able to:
- Describe the landscape of Minimally Invasive Urologic Surgery in Sub Saharan Africa.
- Identify the areas of collaborations in training.
- Propose solutions to bridge the gap and reduce the disparities.
|
|
0955-1010
|
|
State of the Art Lecture: Reducing the Risk of Recurrent Stone Disease: Trials and Challenges
Joe Philip, United Kingdom
|
|
1010-1025
|
|
State of the Art Lecture: Role of SABR in Kidney Cancer for Metastasis Directed Therapy and Local Control of Primary Tumor
Raquibul Hannan, United States
|
|
1025-1030
|
|
Closing Remarks
|
|
|
0945-1145
|
|
SURG-01: Surgery Day - Screen One - Session 2
Room: Anadolu Oditoryum
Chair: Jean de la Rosette, Türkiye
Committee Members: Mélanie Aubé-Peterkin, Canada / Mevlana Derya Balbay, Türkiye / Mihir Desai, United States / Paolo Gontero, Italy / Stavros Gravas, Cyprus / Sung Kyu Hong, South Korea
|
|
Learning Objectives:
At the end of this course, participants should be able to:
- Update their knowledge of recent developments in equipment and technique for the minimally invasive and surgical management of urological diseases, based on live and pre-recorded surgical demonstrations.
- Acknowledge the role of open, laparoscopic, and robotic-assisted surgical procedures in uro-oncology and reconstructive urology, with respect to new systems, instrumentation, and techniques.
- Summarize practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions.
- Recognize the role of focal therapy and novel imaging approaches in uro-oncology.
- Recall perioperative considerations for optimizing urological surgery outcomes, based treatment guidelines and expert opinion.
|
|
|
|
|
Session 2
Moderators
Dean Elterman, Canada
Fadl Hamouche, Canada
Grégoire Robert, France
|
|
1030-1045
|
|
SEMI-LIVE: Moses HOLEP
Surgeon: Ranan Dasgupta, United Kingdom
|
|
1015-1030
|
|
SEMI-LIVE: Transperineal Thermal Ablation with EchoLaser SoracteLite
Surgeon: Francesco Sessa, Italy
|
|
1045-1100
|
|
SEMI-LIVE: Water Vapor Therapy with Rezum
Yongwei Lim, Singapore
|
|
0945-1015
|
|
SEMI-LIVE: Bipolar Transurethral Enucleation of the Prostate with Plough-shaped Electrode and Intelligent Pressure-controlled Morcellator
Surgeon: Li-Ping Xie, People's Republic of China
|
|
1100-1115
|
|
SEMI-LIVE: Aquabeam
Surgeon: Antonio Pastore, Italy
|
|
1115-1130
|
|
SEMI-LIVE: Greenlight Laser Vaporization
Hannes Cash, Germany
|
|
1130-1145
|
|
SEMI-LIVE: ThuLEP
Surgeon: Giorgio Bozzini, Italy
|
|
|
0945-1145
|
|
SURG - 02: Surgery Day - Screen Two - Session 2
Room: Anadolu Oditoryum
Co-Chair: Jean de la Rosette, Türkiye
Committee Members: Mélanie Aubé-Peterkin, Canada / Mevlana Derya Balbay, Türkiye / Mihir Desai, United States / Paolo Gontero, Italy / Sung Kyu Hong, South Korea
|
|
Learning Objectives:
At the end of this course, participants should be able to:
- Update their knowledge of recent developments in equipment and technique for the minimally invasive and surgical management of urological diseases, based on live and pre-recorded surgical demonstrations.
- Acknowledge the role of open, laparoscopic, and robotic-assisted surgical procedures in uro-oncology and reconstructive urology, with respect to new systems, instrumentation, and techniques.
- Summarize practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions.
- Recognize the role of focal therapy and novel imaging approaches in uro-oncology.
- Recall perioperative considerations for optimizing urological surgery outcomes, based treatment guidelines and expert opinion.
|
|
|
|
1030-1100
|
|
Break
Room: Exhibit Hall
|
|
1030-1230
|
|
WS-01: Workshop: Basics on Ultrasonography (USG) in Urology
Room: Rumeli LL6
Co-Chairs: Amit Bhattu, United States / Ravindra Sabnis, India
Faculty: Swapan Sood, India
|
|
Programme Description:
This course will be structured in 3 parts:
- Lectures from the selected faculty will be shared to registered participants as a pre-workshop activity.
- Practical demonstration of key procedure points presented sequentially.
- Hands-on training for participants (up to 5 per USG machine) during active interaction with selected faculty.
Practical Demonstration and Hands-On Training (120 minutes)
Procedures and Techniques:
- Each USG machine will be dedicated to one procedure/technique.
- Procedures will include:
- Upper renal tract
- Lower urinary tract
- Transrectal USG (optional)
- Doppler
Learning Objectives:
At the end of the workshop, the participants should be able to:
- Operate an USG machine.
- Recall the basics of USG imaging for: hydronephrosis, dilated ureters, stones, cysts, renal masses, bladder examination, PVR, bladder volume, wall thickness, masses and stones, prostate evaluation, benign enlargement.
- Recognize the technique for conducting a transrectal USG for diagnosing benign enlargement of prostate, hypoechoic nodules, prostatic calculi, prostatic cysts, prostatic abscess, dilated SV/ejaculatory duct.
- Detail how to make a clinically acceptable USG report.
- Recognize the technique for performing a transrectal prostate biopsy under USG guidance.
- Recall the basics of USG Doppler.
|
|
1100-1230
|
|
CO-01: Controversies in Urology: Genitourinary Tuberculosis – Current Strategies
Room: Rumeli LL2
Co-Chairs: Prem Kumar, India / Guglielmo Mantica, Italy
|
|
Learning Objectives:
At the end of the session, attendees should be able to
- Be aware of the new diagnostic and therapeutic perspectives regarding the treatment of GUTB.
- Identify the closest relationships between GUTB and infertility, but also between GUTB and CKD.
- Understand the association between GUTB and genitourinary neoplasms, in particular with bladder cancer, will be evaluated in detail. In particular, current diagnostic-therapeutic approaches and future perspectives will be evaluated.
- Particularly insidious and interesting clinical cases will be presented and discussed together in order to be able to evaluate any pitfalls in the diagnostic-therapeutic process of patients with GUTB.
- Provide mentoring opportunities and guidance for urologic trainees.
|
|
|
|
1100-1230
|
|
HT-03: Hot Topic: Neoadjuvant Therapy in MIBC
Room: Rumeli LL5
Co-Chairs: Peter Albers, Germany / Andrea Necchi, Italy
|
|
|
|
1100-1230
|
|
IC-02: Instructional Course: Basic Concepts and Clinical Applications of Genetic and Genomic Testing for Urologists
Room: Hisar
Chair: Leonard Gomella, United States
|
|
The use of genetic and genomic testing to guide treatment decisions in the management of urologic malignancies has expanded greatly. Urologists are becoming more involved in the application of precision medicine using genetic and genomic testing. In particular, the application of this technology has impacted all stages of prostate cancer management, from screening for early detection through the treatment choices for advanced castration resistant disease. It is critical that Urologists become familiar with how to best use these new technologies to treat their patients.
Learning Objectives:
At the end of this session, attendees should be able to:
- Understand basic concepts and technologies used in genetic and genomic testing.
- Differentiate germline and somatic testing and the use of circulating tumor (DNA) ctDNA.
- Identify the common actionable genetic alterations in common diseases such as prostate cancer.
- Understand guidelines for testing for inherited urologic cancer syndromes.
- Review the current and future applications of genomic testing in patient treatment decisions.
|
|
|
|
1100-1230
|
|
IS-05: Interactive Session: Management of OAB – Issues and Challenges
Room: Rumeli LL3
Co-Chairs: Tohid MS Hossain, Bangladesh / Andrea Tubaro, Italy
|
|
|
|
1100-1230
|
|
IS-04: Interactive Session: Castrate-resistant Prostate Cancer – Available Options and Future
Room: Rumeli LL9
Co-Chairs: Nicola Longo, Italy / Sudhir Rawal, India
|
|
1100-1112
|
|
The Molecular Biology of Androgen Receptor Signaling in Castrate-resistant Prostate Cancer
|
|
1112-1124
|
|
Current Role of Lu-PSMA
Daniel Moon, Australia
|
|
1124-1136
|
|
Status of Predictive and Prognostic Biomarkers in Castrate-resistant Prostate Cancer
Brusabhanu Nayak, India
|
|
1136-1148
|
|
Evolving Role of PARP Inhibitors in Castrate-resistant Prostate cancer
|
|
1148-1200
|
|
PSMA Theranostics in Prostate Cancer
Theodoros Kalogeropoulos, Greece
|
|
1200-1230
|
|
Discussion
|
|
|
1100-1230
|
|
JS-01: Joint SIU/Endourological Society Session
Room: Rumeli LL4
Co-Chairs: Athanasios (Thanos) Papatsoris, Greece / Omer Levent Tuncay, Türkiye
|
|
Learning Objectives:
At the end of this session, attendees should:
- Understand about the surgical treatment of impacted ureter stones.
- Understand about the different approaches for urinary diverticulum stones.
- Understand about the different applications of laser for urological conditions.
- Understand which laser fits best for which treatment.
|
|
1100-1105
|
|
Welcome
Omer Levent Tuncay, Türkiye
|
|
1105-1115
|
|
A 1 cm Renal Pelvis Stone – I Recommend SWL
Kah Ann Git, Malaysia
|
|
1115-1125
|
|
A 1 cm Renal Pelvis Stone – I Recommend Mini PCNL
|
|
1125-1135
|
|
Holmium Laser is Best for a Hard 1 cm Stone
Anastasios Anastasiadis, Greece
|
|
1135-1145
|
|
Thulium Laser is Best for a Hard 1 cm Stone
Gökhan Atış, Türkiye
|
|
1145-1155
|
|
Round Table Discussion
Moderators
Ranan Dasgupta, United Kingdom
İlker Seçkiner, Türkiye
|
|
1155-1205
|
|
mpMRI for Prostate Cancer Diagnosis
Baris Bakir, Türkiye
|
|
1205-1215
|
|
Micro-ultrasound for Prostate Cancer Diagnosis
Cosimo de Nunzio, Italy
|
|
1215-1225
|
|
PSMA for Prostate Cancer Diagnosis
Fuat Kızılay, Türkiye
|
|
1225-1230
|
|
Summary and conclusion
Athanasios (Thanos) Papatsoris, Greece
|
|
|
1100-1230
|
|
MC-02: Master Class: VUR and Recurrent UTI in Children
Room: Rumeli LL1
Co-Chairs: R B Nerli, India / Isteaq Ahmed Shameem, Bangladesh
|
|
|
|
1100-1230
|
|
TIPS-01: SIU Tips and Tricks Pt 1: Academy - Minimally Invasive and Conventional Endoscopic Procedures for BPE
Room: Rumeli LL12
Chair: Mauro Gacci, Italy
|
|
Learning Objectives:
At the end of this session, attendees will:
- Learn the indications for MISt vs. conventional endoscopy for BPE.
- Understand the differences between lasers used for BPE.
- Update on the outcomes of the latest minimally invasive techniques
|
|
|
|
1200-1400
|
|
SURG-01: Surgery Day - Screen One - Session 3
Room: Anadolu Oditoryum
Chair: Jean de la Rosette, Türkiye
Committee Members: Mélanie Aubé-Peterkin, Canada / Mevlana Derya Balbay, Türkiye / Mihir Desai, United States / Paolo Gontero, Italy / Stavros Gravas, Cyprus / Sung Kyu Hong, South Korea
|
|
Learning Objectives:
At the end of this course, participants should be able to:
- Update their knowledge of recent developments in equipment and technique for the minimally invasive and surgical management of urological diseases, based on live and pre-recorded surgical demonstrations.
- Acknowledge the role of open, laparoscopic, and robotic-assisted surgical procedures in uro-oncology and reconstructive urology, with respect to new systems, instrumentation, and techniques.
- Summarize practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions.
- Recognize the role of focal therapy and novel imaging approaches in uro-oncology.
- Recall perioperative considerations for optimizing urological surgery outcomes, based treatment guidelines and expert opinion.
|
|
|
|
1200-1400
|
|
SURG-02: Surgery Day - Screen Two - Session 3
Room: Anadolu Oditoryum
Chair: Jean de la Rosette, Türkiye
Committee Members: Mevlana Derya Balbay, Türkiye / Mihir Desai, United States / Paolo Gontero, Italy / Stavros Gravas, Cyprus / Sung Kyu Hong, South Korea
Moderator: Pilar Laguna, Türkiye
|
|
Learning Objectives:
At the end of this course, participants should be able to:
- Update their knowledge of recent developments in equipment and technique for the minimally invasive and surgical management of urological diseases, based on live and pre-recorded surgical demonstrations.
- Acknowledge the role of open, laparoscopic, and robotic-assisted surgical procedures in uro-oncology and reconstructive urology, with respect to new systems, instrumentation, and techniques.
- Summarize practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions.
- Recognize the role of focal therapy and novel imaging approaches in uro-oncology.
- Recall perioperative considerations for optimizing urological surgery outcomes, based treatment guidelines and expert opinion.
|
|
|
|
1230-1345
|
|
Networking Lunch
Room: Exhibit Hall
|
|
1300-1700
|
|
IPF: International Prostate Forum (IPF) Conference – Controversies in Prostate Cancer Management
Room: Marmara
Co-Chairs: Mevlana Derya Balbay, Türkiye / A. Erdem Canda, Türkiye / John Davis, United States
|
|
Learning Objectives
At the end of this sessions, attendees should:
- Understand about the different diagnostic (imaging) modalities for prostate carcinoma.
- Understand about the different biopsy protocols for prostate carcinoma.
- Understand the position of PSMA PET scanning to stage prostate carcinoma
- Understand about the medical treatment options for advanced prostate cancer
- Understand about the advancements in minimal invasive treatment options for benign and malignant treatment options.
- Understand the position of Focal Therapy within the armamentarium for treatment options of localized prostate carcinoma.
- Understand of the advancements in surgical technique for prostate carcinoma
|
|
1300-1305
|
|
Introduction to the International Prostate Forum 2023 at the SIU
Mevlana Derya Balbay, Türkiye
A. Erdem Canda, Türkiye
John Davis, United States
|
|
|
|
Controversy 1: Prostate Cancer Diagnostics in 2023—Best Solutions for Worldwide Practice?
Moderators
Saad Aldousari, Kuwait
Nicolae Crisan, Romania
Mudhar Nazar Hasan, United Arab Emirates
|
|
1305-1315
|
|
Are Secondary Biomarkers Accessible, Useful?
Imogen Patterson, Australia
|
|
1315-1325
|
|
MRI Update - Progress in Magnet Strength, Image Protocols, and Reading
Bengi Gürses, Türkiye
|
|
1325-1335
|
|
Optimal Biopsy Technique—Fusion, Transperineal, or None at All?
Petr Macek, France
|
|
1335-1350
|
|
Moderator Led Discussion—What are Your Most Useful Resources in Diagnostics?
|
|
|
|
Controversy 2: PSMA PET Induced Stage Migration in High-Risk and Recurrent Prostate Cancer—How to Unblur the Lines Between Curable and Non-curable Disease?
Moderators
Daniel Eberli, Switzerland
Raja Khauli, Lebanon
Uğur Selek, Türkiye
David Gillatt, Australia
|
|
1350-1400
|
|
PSMA PET Metrics: What Are Its Strengths and Limitations? Should It Be fused With CT, MRI, or Spect?
Meltem Çağlar, Türkiye
|
|
1400-1410
|
|
High Risk Disease With PSMA PET-only Detectable Positive Lymph Nodes— Extended PLND vs Radiation/ADT?
Derya Tilki, Germany
|
|
1410-1420
|
|
PSMA PET Detected Metastatic Disease—Is Metastasis Directed Therapy the Standard?
Yasemin Bölükbaşı, Türkiye
|
|
1420-1435
|
|
Moderator Led Discussion—How Has PSMA PET Improved Your Patient Outcomes?
|
|
|
|
Controversy 3: Surgical Techniques Forum—Where Are We Making Progress
Moderators
Mario Álvarez-Maestro, Spain
Vincenzo Ficarra, Italy
Dmitry Pushkar, Russia
Hector R. Vargas-Zamora, Mexico
|
|
1435-1445
|
|
Small Space and/or Anterior Tissue Preserving Techniques—Is Continence Better?
Sudhir Rawal, India
|
|
1445-1455
|
|
Focal Therapy Persistent/Progressive Disease—What Are Our Best Salvage Options?
Franck Bladou, France
|
|
1455-1505
|
|
The Hostile Abdomen Unsafe for Transperitoneal RARP: Who Has the Best Solution? Extraperitoneal, Perineal, Transvesical, or none?
John Davis, United States
|
|
1505-1520
|
|
Moderator Led Discussion: What Are Our Most Difficult Surgical Challenges?
|
|
|
|
Controversy 4: Metastatic Prostate Cancer—Is Earlier and With More Drugs the Answer?
Moderators
Evgeny Bezrukov, Russia
Archil Chkhotua, Georgia
Ming Liu, China
Ozcan Yildiz, Türkiye
|
|
1520-1530
|
|
Hormone Sensitive Disease—Double vs Triple Therapy
Makarand Kochikar, India
|
|
1530-1540
|
|
Castrate Resistant Disease—What are the Most Promising Mechanisms Beyond Androgen and Androgen Receptor Manipulation?
Karima Oualla, Morocco
|
|
1540-1550
|
|
When and How to Control the Primary Tumor in Metastatic Disease
Weranja Ranasinghe, Australia
|
|
1550-1605
|
|
Moderator Led Discussion: Progress With Extending Survival and Maintaining Quality of Life
|
|
|
|
Controversy 5: Minimally Invasive Prostate Tissue Ablation
Moderators
Kamel Ait el Hadj, Algeria
Raed Azhar, Saudi Arabia
Joyce Baard, The Netherlands
Susan MacDonald, United States
|
|
1605-1615
|
|
Can LUTS Be Surgically Cured Without Ejaculatory Dysfunction?
Albert El Hajj, Lebanon
|
|
1615-1625
|
|
Debate Punchlines: The Massive Prostate: HOLEP vs Robotic Simple
Yadup Kordan, Türkiye
|
|
1625-1635
|
|
Tissue Ablation Successes: Laser Ablations for Cancer and Embolization for BPH
Rick Popert, United Kingdom
|
|
1635-1650
|
|
Moderator Led Discussion: Do We Need an Interventional Radiology Sub-specialty for Urologists?
|
|
1650-1700
|
|
Debrief With Prof Atif Akdas, Video Message From Professors Babaian and Watanabe, Final Q&A
Atif Akdas, Türkiye
Mevlana Derya Balbay, Türkiye
A. Erdem Canda, Türkiye
John Davis, United States
|
|
|
1345-1515
|
|
SYMP-17: Hellenic Urology Association (HUA) Lecture; International Continence Society (ICS) Lecture and Late Breaking Abstracts
Room: Rumeli LL4
Co-Chair: Bhojraj Luitel, Nepal
Speaker: Rajeev T P, India
|
|
1345-1350
|
|
Welcome and Introductions
|
|
1350-1410
|
|
Hellenic Urological Association Lecture: Novel disposable fURS
Athanasios (Thanos) Papatsoris, Greece
|
|
1410-1430
|
|
International Continence Society Lecture: The IMPROVE Trial: Surgical Technique Remains The Most Important Factor Associated With Recovery of Urinary Continence After Radical Prostatectomy
Rafael Sanchez-Salas, Canada
|
|
1430-1515
|
|
Late Breaking Abstracts
|
|
|
1345-1515
|
|
HT-04: Hot Topic: MIBC – Optimizing TURBT, Radical Cystectomy and PLND
Room: Rumeli LL3
Co-Chairs: Mario I. Fernández, Chile / Seth Lerner, United States
|
|
|
|
1345-1515
|
|
IC-03: Instructional Course: New Tools for Optimizing Prostate Cancer Management
Room: Rumeli LL2
Chair: Gonzalo Vitagliano, Argentina
Co-Chair: Robert Reiter, United States
|
|
New diagnostic tools for prostate cancer have emerged in recent years. However, effective and efficient use remains to be determined. This session aims to stablish the practical role of these new technologies in the prostate cancer management algorithm.
Learning Objective:
At the end of this session, attendees:
- Will have learned the proper use of new diagnostic and staging tools in prostate cancer.
|
|
|
|
1345-1515
|
|
IS-06: Interactive Session: Optimising IC / BPS Results
Room: Rumeli LL1
Co-Chairs: Nagendra Nath Mishra, India / Michael Samarinas, Greece
|
|
|
|
1345-1515
|
|
MC-03: Master Class: Navigating the Management of Small Renal Masses
Room: Rumeli LL9
Co-Chairs: Muddassar Hussain, United Kingdom / Pilar Laguna, Türkiye / Michael Marberger, Austria
|
|
Learning Objectives:
Most of the currently diagnosed renal tumors are classed as small renal masses (SRM) with a maximum size diameter of 4 cm. besides the fact that a non-negligible percentage of them are benign, few of them are potentially aggressive and even though, they may not require active treatment as other competing causes will ultimately modulate the life expectancy of the patients.
A must that should prevail when facing a SRM is how to integrate the imaging and histology at hand in the diagnostic algorithm. Furthermore, there are other factors that play an important role in the treatment decision making, some of them require of a through appraisal of the general status of the patients and may or not be modifiable and others depend on the means available in the working setting. All in the frame of a comprehensive discussion and shared decision between the treating physician and the patient.
During this session the attendants will become acquainted with the definition of SRM and on the role of advanced imaging and of the histology in the diagnosis. They will learn the value of well-designed and conducted registries, and the different options to be discussed with the patients from active surveillance to robotic surgery. In summary who should be treated and what is the best option of treatment for a given patient.
A mini debate will point out the pros and cons of two modalities of active treatment (Ablation vs Robotic partial nephrectomy) and lastly a real case will be presented and discussed among the panel with active participation of the attendees.
|
|
|
|
1345-1515
|
|
MP-01: Moderated Oral ePoster Session 01: Kidney and Ureteral Cancer - Basic Science, Pediatric Urology, Prostate Cancer - Basic Science and Stones - Evaluation & Medical Management
Room: Rumeli LL5
Moderators: Neeraj Agarwal, India / Manal Kumar, United Kingdom
|
|
MP-01.01 Impact of Environmental Exposure of Heavy Metals and Toxic Elements on Renal Cell Carcinoma
Brusabhanu Nayak, India
MP-01.02 Understanding the Molecular Characteristics and Vulnerabilities of Sarcomatoid/rhabdoid Renal Cell Carcinomas Through Integrative Histological and Spatial Genomics Approaches
Mustafa Soytas, Canada
MP-01.03 Comparative Analysis of Cystolitholapaxy and Percutaneous Cystolithotripsy in Senior Pediatric Population Aged 6 to 15 Years
Tariq Ahmad, Pakistan
MP-01.04 Efficacy and Safety of Endoscopic Balloon Dilatation for Treatment of Primary Obstructed Megaureter up to 2 Years of Age
Tariq Ahmad, Pakistan
MP-01.05 Efficacy and Safety of Mirabegron Compared to Solifenacin in Treatment of Non-Neurogenic Voiding Dysfunction in Children: a Randomized Controlled Trial.
Islam Mansour, Egypt, Arab Rep.
MP-01.06 Hoga1 Variants in Chinese Patients with Primary Hyperoxaluria Type 3: Genetic Features and Genotype-Phenotype Relationships
Wenying Wang, China
MP-01.07 Is Percutaneous Nephrolithotomy Effective and Safe in Infants Younger than 2 Years Old? Comparison of Mini and Standard Percutaneous Nephrolithotomy
Nebil Akdogan, Türkiye
MP-01.08 Our Experience in Severe Hypospadias Repair by One-Stage Lengthening Procedure
Marko Bencic, Serbia
MP-01.09 Preoperative Factors Associated with the Development of Distal Ureteral Stump Syndrome After Upper Pole Heminephrectomy
Eric Kurzrock, United States
MP-01.10 Safety and Efficacy of Transurethral Cystolithotripsy for Bladder Stone in Pediatric Population. Single Centre Experience.
Tariq Ahmad, Pakistan
MP-01.11 Clinical Characterization of Metastatic Hormone Sensitive Prostate Cancer According to Real Word Data: Can Randomized Clinical Trials Be More Reliable? Data From the European Network of Excellence for Big Data in Prostate Cancer (Pioneer).
Rossella Nicoletti, Italy
MP-01.12 Development of a Predictive Model for Death Amongst Patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated with One of the Approved Treatment Plans, on Characteristics Present at Admission: Preliminary Results From the European Networ
Rossella Nicoletti, Italy
MP-01.13 Mechanism of Il-6/stat3 Regulation of Srd5a1 in Prostate Cancer Cells
Xiaobo Wu, Hong Kong, China
MP-01.14 Randomized Trial Comparing Different Methods of Lymphogenic Complications Prophylaxis During Robot-Assisted Radical Prostatectomy.
Dmitry Pushkar, Russian Federation
MP-01.15 Snd1 Regulates the mRNA Stabilization Through m6A Modification to Promote Prostate Cancer Progression
Yijie Tang, China
MP-01.16 The Crl3-Spop Ubiquitin Ligase Complex Decreases the Transcriptional Output of Hippo-Yap Signaling by Promoting Tead2 Degradation in Prostate Cancer
Kun Chang, China
MP-01.17 Two Major Types of Tumor-Associated Macrophages Have Distinct Correlation with Progression of Prostate Cancer
Valentin Pavlov, Russian Federation
MP-01.18 A Randomized, Double-Blind, Placebo-Controlled Study of Agropyron Repens, Mannitol and Magnesium Supplement for the Treatment of Calcium Oxalate Upper Urinary Tract Stones: the Ammos Study-Preliminary Results
Petros Sountoulides, Greece
MP-01.19 Current State of Mobile Health Apps in Endourology
Ali Talyshinskii, Kazakhstan
MP-01.20 For Communities with Prolonged Inbreeding as in Pakistan, Extensive Metabolic Panels Are Required to Categorize Pathogenicity of Heterozygous AR Variants, Discovered in 34% of Urinary Stone Formers Selected as at-Risk for Genetic Cause.
Syed Biyabani, Pakistan
MP-01.21 Possible Role of the Microbiota in Urinary Stones: a Prospective Study to Correlate Radiological Density (Hounsfield Units) and Cultural Examination of Urinary Calculi
Antonio Luigi Pastore, Italy
MP-01.22 The Protective Effect of Remote Ischemic Preconditioning on Kidney Injury Induced by After Percutaneous Nephrolithotomy Surgery
Guangyuan Zhang, China
MP-04.07 Complex Reconstructive Surgery in Genitourinary Tuberculosis: Multicentric Experience
NEERAJ AGRAWAL, India
|
|
1345-1515
|
|
MVP-01: Moderated Video ePoster Session 01: Bladder Cancer - Basic Science, BPO/LUTS, Female Urology, Kidney and Ureter, Benign Diseases, Renal Transplantation, Sexual Dysfunction and Voiding Dysfunction
Room: Rumeli LL7
Moderators: Damien Bolton, Australia / Vikas Jain, India
|
|
MVP-01.01 Comparative Analysis of the Usage of Open and Laparoscopic Access in Radical Cystectomy with the Formation of an Ileum Conduit
Sergey Kotov
MVP-01.02 Robot-Assisted Laparoscopic Madigan Seminal Sparing Simple Prostatectomy
Antonio Luigi Pastore
MVP-01.03 Transurethral Resection and Buccal Mucosal Graft for the Treatment of Refractory Bladder Neck Contracture
Ibragim Mamaev
MVP-01.04 A Successful Transperitoneal Laparoscopic Repair of Iatrogenic Vesicovaginal Fistula
Sara Duarte, Portugal
MVP-01.05 Laparoscopic Retroperitoneal Pyelolithotomy in Pelvic Ectopic Kidney
Naveed Khan, India
MVP-01.06 Laparoscopic Retroperitoneal Pyeloplasty: Our Experience and Tricks Involved in Its Execution.
Naveed Khan, India
MVP-01.07 Right Complex Challenging Donor Kidney (Three Renal Arteries with Aml) with Robotic Kidney Transplant
Karandeep Guleria, India
MVP-01.08 Shaeer's Cavernotome : the Coring / Grinding Cavernotome for Cases of Corporal Scarring
Osama Shaeer, Egypt, Arab Rep.
MVP-01.09 Shaeer's Single-Corporotomy Infrapubic Penile Prosthesis Implantation
Osama Shaeer, Egypt, Arab Rep.
MVP-01.10 Autologous Fascial Sling Surgery After Orthotopic Urinary Diversion
Mesut Şengül, Türkiye
|
|
1345-1515
|
|
TIPS-02: SIU Tips and Tricks Pt 2: SIUJ
Room: Rumeli LL12
Chair: Peter Black, Canada
|
|
|
|
1345-1615
|
|
GAF-01: Global Andrology Forum Workshop: Evaluation of the Infertile Male – What the Urologist Should Know
Room: Hisar
Chair: Ashok Agarwal, United States
Co-Chair: Giovanni Colpi, Switzerland
|
|
1345-1355
|
|
Introduction to the Workshop
Ashok Agarwal, United States
|
|
1355-1405
|
|
The WHO Sixth Manual on Semen Examination – What is New and Different?
Amarnath Rambhatla, United States
|
|
1405-1415
|
|
Hormonal Evaluation of the Sub-fertile Male – Which, When and Why?
Ayman Rashed, Egypt
|
|
1415-1425
|
|
Sperm DNA Fragmentation Testing – Why is it so Important?
Imad Ziouziou, Morocco
|
|
1425-1435
|
|
Oxidative Stress Measurement – Is it the Missing Link?
Ashok Agarwal, United States
|
|
1435-1445
|
|
Genetic Testing of Infertile Men – Indications and Clinical Implications
Sezgin Güneş, Türkiye
|
|
1445-1455
|
|
Artificial Intelligence – Its Role in Male Infertility
Widi Atmoko, Indonesia
|
|
1455-1505
|
|
Controversies in Varicocele Diagnosis and Management
Tan V Le, Vietnam
|
|
1505-1515
|
|
Varicocele – Comparison of Outcomes with Various Techniques
Ates Kadioğlu, Türkiye
|
|
1515-1525
|
|
Future of Andrology?
Nikolaos Sofikitis, Greece
|
|
1525-1555
|
|
Q&A
Moderators
Selahittin Çayan, Türkiye
Lukman Hakim, Indonesia
|
|
1555-1605
|
|
Take Home Messages
A Barış Altay, Türkiye
|
|
|
1415-1630
|
|
SURG - 01: Surgery Day - Screen One - Session 4
Room: Anadolu Oditoryum
Chair: Jean de la Rosette, Türkiye
Committee Members: Mélanie Aubé-Peterkin, Canada / Mevlana Derya Balbay, Türkiye / Mihir Desai, United States / Paolo Gontero, Italy / Stavros Gravas, Cyprus / Sung Kyu Hong, South Korea
|
|
Learning Objectives:
At the end of this course, participants should be able to:
- Update their knowledge of recent developments in equipment and technique for the minimally invasive and surgical management of urological diseases, based on live and pre-recorded surgical demonstrations.
- Acknowledge the role of open, laparoscopic, and robotic-assisted surgical procedures in uro-oncology and reconstructive urology, with respect to new systems, instrumentation, and techniques.
- Summarize practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions.
- Recognize the role of focal therapy and novel imaging approaches in uro-oncology.
- Recall perioperative considerations for optimizing urological surgery outcomes, based treatment guidelines and expert opinion.
|
|
|
|
1415-1630
|
|
SURG-02: Surgery Day - Screen Two - Session 4
Room: Anadolu Oditoryum
Chair: Jean de la Rosette, Türkiye
Committee Members: Mélanie Aubé-Peterkin, Canada / Mevlana Derya Balbay, Türkiye / Mihir Desai, United States / Paolo Gontero, Italy / Stavros Gravas, Cyprus / Sung Kyu Hong, South Korea
|
|
Learning Objectives:
At the end of this course, participants should be able to:
- Update their knowledge of recent developments in equipment and technique for the minimally invasive and surgical management of urological diseases, based on live and pre-recorded surgical demonstrations.
- Acknowledge the role of open, laparoscopic, and robotic-assisted surgical procedures in uro-oncology and reconstructive urology, with respect to new systems, instrumentation, and techniques.
- Summarize practical knowledge of instrumentation and techniques for the endourologic treatment of upper and lower urinary tract conditions.
- Recognize the role of focal therapy and novel imaging approaches in uro-oncology.
- Recall perioperative considerations for optimizing urological surgery outcomes, based treatment guidelines and expert opinion.
|
|
|
|
1515-1545
|
|
Break
Room: Exhibit Hall
|
|
1515-1545
|
|
SS-01: Studio Session - What’s New to Optimise Individualised Care for LUTS/BPE?
Room: SIU@U Studio, Exhibit Hall
Chair: Stavros Gravas, Cyprus
Faculty: Sung Yong Cho, South Korea / Marie Carmela Lapitan, Philippines
|
|
Learning Objectives:
At the end of this scientific studio session, participants should be able to:
- Better understand the effect of medical treatments in profiles of men with LUTS/BPE on changes in different type of symptoms and QoL as well as risk of AUR or related surgery.
- Recognise the role of clinically relevant baseline characteristics in modulating response to various medical treatments in individual patient profiles.
- Acknowledge how predictive modelling and innovative ways to visualise complex science help to inform optimal care.
- Appreciate the importance of a better-informed individualised management of LUTS/BPE patients.
|
|
1545-1715
|
|
CO-02: Controversies in Urology: Confronting the Contemporary Challenges in Upper Tract Urothelial Cancer
Room: Rumeli LL2
Co-Chairs: Salah Albuheissi, United Kingdom / Amlesh Seth, India
|
|
1545-1555
|
|
Role of Conservative Management in the Treatment of Upper Tract Urothelial Cancer: Controversies and Challenges
Joe Philip, United Kingdom
|
|
1555-1605
|
|
Optimal Approach to Surgical Management of Upper Tract Urothelial Cancer
A. Erdem Canda, Türkiye
|
|
1605-1615
|
|
Emerging Therapies for Upper Tract Urothelial Cancer
Bedeir Ali El Dein, Egypt
|
|
1615-1625
|
|
Role of Lymph Node Dissection in the Management of Upper Tract Urothelial Cancer: Controversies and Challenges
Amlesh Seth, India
|
|
1625-1635
|
|
Role of Adjuvant Therapy in the Management of Upper Tract Urothelial: Controversies and Challenges
Ozcan Yildiz, Türkiye
|
|
1635-1645
|
|
Systemic Chemotherapy for Upper Tract Urothelial Cancer: Efficacy and Outcomes
Shilpa Gupta, United States
|
|
1645-1715
|
|
Discussion
|
|
|
1545-1715
|
|
IC-04: Instructional Course: Perioperative Immunotherapy Treatments of Localized Genitourinary Malignancies
Room: Rumeli LL3
Chair: Andrea Necchi, Italy
|
|
Learning Objectives:
At the end of this session, attendees should be able:
- To increase the knowledge and the awareness among urologists on the developments of systemic immunotherapy as perioperative therapy in urologic cancers.
- To understand which are the currently-recommended management strategies and the newly approved adjuvant immunotherapies.
- To learn how to best incorporate these new developments into the standard-of-care treatment.
- To understand what are the unmet needs and the management gaps from patients' advocates voice.
|
|
1545-1605
|
|
Fresh Data on the Use of Neoadjuvant and Adjuvant Immunotherapy in Resectable GU Malignancies
Shilpa Gupta, United States
|
|
1605-1625
|
|
Integrating the Research Developments into ihe Standard of Care: The Role of Medical Oncologist
Andrea Necchi, Italy
|
|
1625-1645
|
|
Practice Management of Multimodal Therapy, including Safety and Bladder Preservation: The Urologist Perspective
Philippe E Spiess, United States
|
|
1645-1715
|
|
Discussion Guided by Faculty
MAIN TOPICS:
- Clinical scenarios of the modern management of patients with muscle-invasive bladder cancer (MIBC)
- Involvement of patient advocates into the clinical decision making
- Management of unexpected events in daily management: adverse events, surgery delays, with guidance provided by Faculty experts
|
|
|
1545-1715
|
|
IS-07: Interactive Session: Lymph Node Management in Carcinoma Penis – Principles and Issues
Room: Rumeli LL1
Co-Chairs: Samir Khanna, India / Bhojraj Luitel, Nepal
|
|
|
|
1545-1715
|
|
MV-01: Master Video: Energies in Stone Fragmentation – Advances and Outcome
Room: Rumeli LL9
Co-Chairs: Kalana Parana Palliya Guruge, Sri Lanka / Dilip Mishra, India
|
|
|
|
1545-1715
|
|
MP-02: Moderated Oral ePoster Session 02: Kidney and Ureter, Benign Diseases and Kidney and Ureteral Cancer – Clinical
Room: Rumeli LL5
Moderators: M Hammad Ather, Pakistan / V Rajagopal, India
|
|
MP-02.01 A New Ureteric Pigtail Suture Stent to Improve Patient's Quality of Life: a Pilot Study
Mohamed FARAH, United Kingdom
MP-02.02 How Does Intrarenal Pressures Affect the Nephron? the Effect of Raised Intrarenal Pressures on an Ex Vivo Animal Model
Anne Hong, Australia
MP-02.03 Influence of Simple Renal Cysts on Renal Function: Prospective Randomized Clinical Trial
Vigen Malkhasyan, Russian Federation
MP-02.04 Laparoscopic Nephrectomy in Xanthogranulomatous Pyelonephritis: Assessment of Feasibility and Factors Predicting Difficulties
Yash Pamecha, India
MP-02.05 Plasma-Derived Exosomal Mir-4635 as a Promising Diagnostic Biomarker for Early Detection of Aki After Cardiac Surgery
Xiangyu Zou, China
MP-02.06 Visualising the Effects of Raised Intrarenal Pressures on the Renal Parenchyma
Anne Hong, Australia
MP-02.07 3d Anatomic Reconstruction as a Tool for Partial Nephrectomy Planning Based on Anatomic Variations of the Renal Hilum.
Gonzalo Vitagliano, Argentina
MP-02.08 Association Between the Sarcomatoid Status and Percentage of Sarcomatoid Feature on the Clinical Outcomes of Localized Renal Cell Carcinoma Post Nephrectomy
Mustafa Soytas, Canada
MP-02.09 Clinical Outcomes of Patients with Metastatic Renal Cell Carcinoma with or without Sarcomatoid Features Treated with Systemic Therapies in Real-World Canadian Setting
Ghady B-N Sawaya, Canada
MP-02.10 Clinical Outcomes of Patients with Metastatic Renal Rell Carcinoma with or without Sarcomatoid Features Treated with Combination Therapies in Real-World Canadian Setting
Ghady B-N Sawaya, Canada
MP-02.11 Comparative Assessment Efficacy 2 vs 4 Cycles of Neoadjuvant Targeted Therapy in Patients with Localized RCC
Oleg Voylenko, Ukraine
MP-02.12 Decline of Ipsilateral Gfr Beyond New Baseline for Patients with Clamped Partial Nephrectomy
Zhaohui Zhou, China
MP-02.13 Holmium:Yag versus Thulium:Yag Laser in Endoscopic Ablation of Upper Tract Urothelial Carcinoma: a Comparison on Perioperative Outcomes and Short-Term Follow-Up
Davide Perri, Italy
MP-02.14 Influence of Central Ischemia on the Renal Function and Comorbidities After Partial Nephrectomy in Patients with Localized RCC
Oleg Voylenko, Ukraine
MP-02.15 Is Adjuvant Pembrolizumab After Nephrectomy in Renal-Cell Carcinoma Really Superior?
Gonzalo Vitagliano, Argentina
MP-02.16 New Approaches to Fast-Track Surgery After Partial Nephrectomy
Oleg Voylenko, Ukraine
MP-02.17 Predictors of Positive Surgical Margins Before Surgery for Renal Cell Carcinoma
Ogulcan Canitez, Türkiye
MP-02.18 Prognostic Significance of Grade Discrepancy Between Primary Tumor and Venous Thrombus in Non-Metastatic Clear-Cell Renal Cell Carcinoma: Analysis of the Remember Registry and Implications for Adjuvant Therapy
Zhenjie Wu, China
MP-02.19 Renal Cell Carcinoma Subtype, Tumor Size and Risk of Synchronous Metastases: a Report From the National Cancer Database
Heinric Williams, United States
MP-02.20 Robot-Assisted Inferior Vena Cava Thrombectomy and Radical Nephrectomy: Experiences and Techniques with 2-Yr Outcomes
Xiaoping Zhang, China
MP-02.21 Segmental Resection Has Equivalent Oncological Outcomes to Radical Nephroureterectomy for Ureteral Urothelial Carcinoma
Jeremy Teoh, China
MP-02.22 The Novel Holographic-Image-Based Surgical Difficulty System to Guide Partial Nephrectomy in Renal Tumor
Liu Zhengsheng, China
|
|
1545-1715
|
|
MP-03: Moderated Oral ePoster Session 03: Bladder Cancer - Basic Science, Bladder Cancer – Clinical and Miscellaneous (cancer related)
Room: Rumeli LL7
Moderators: Grigorakis Alkiviadis, Greece / Michael Poch, United States
|
|
MP-03.01 B7-H4 Correlates with Clinical Outcome and Immunotherapeutic Benefit in Muscle-Invasive Bladder Cancer
Zhaopei Liu, China
MP-03.02 Bladder Cancer Associated with Elevated Level of Lead, Cadmium, Aluminum and Zinc: Prognostic Significance of Metal Elevation and Expression of Fgfr3, Gata3 and Cytokeratin 5/6
Bedeir Ali-El-Dein, Egypt, Arab Rep.
MP-03.03 Machine Learning Algorithm for Diagnosis of Urologic Malignancies Using Analysis of Copy Number Variation in Urinary Cell Free DNA
Myung Soo Kim, Korea, Rep.
MP-03.04 Optical Markers as Predictors of Recurrence and Progression in Patients with Non-Muscle Invasive Bladder Cancer.
Valentin Pavlov, Russian Federation
MP-03.05 Tigit and PD-1 Expression Atlas Predicts Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer
Yu Zhu, China
MP-03.06 A Systematic Review of Robotic vs Open Cystectomy with Detailed Peri-Operative Outcomes and Complication Profile
Finin Cotter, Australia
MP-03.07 Association of Patient Characteristics (Basic and Clinical) with Genitourinary Tract Malignancies in Patients Presenting with Microscopic Hematuria: a Single Canadian Centre Experience
Loay Abbas, Canada
MP-03.08 Changes of Exosomal Urinary PD-L1 Concentration After PD-L1 Inhibitor Therapy in Metastatic Bladder Cancer Patients Refractory to Cisplatin Based Chemotherapy
Kyung Hwan Kim, Korea, Rep.
MP-03.09 Clinical Outcomes of Patients with Variant Histology of Urothelial Carcinoma After Radical Cystectomy
Yun Ha Lee, Korea, Rep.
MP-03.10 Comparison of en-Bloc Resection of the Bladder Wall with Conventional Tran-Surethral Resection of the Bladder Wall in Patients with Bladder Cancer.
Sergey Kotov, Russian Federation
MP-03.11 Dwi-Based Multi-Regional Radiomics Model for the Assessment of Muscle Invasion in Bladder Cancer
Mingyang Li, China
MP-03.12 Fully Automated Bladder Tumor Segmentation From MRI Images, Using 3d U-Net AI-Based Algorithm
Teodora Telecan, Romania
MP-03.13 Is There Any Possible Role for 5 Alpha Reductase Inhibitors in Non Muscle Invasive Bladder Caner? Results From Multicenter Study
Antonio Luigi Pastore, Italy
MP-03.14 Laparoscopic 3d Radical Cystectomy with Intracorporeal Urinary Diversion - Our Experience
Maximilian Buzoianu, Romania
MP-03.15 Multiple Directional Dwi Combined with T2wi in Predicting Muscle Layer and Ki-67 Correlation in Bladder Cancer in 3.0-T MRI
Yongbao Wei, China
MP-03.16 Paraganglioma (Pheochromocytoma) of the Urinary Bladder: a Systematic Review with a Diagnostic, Management and Treatment Algorithm
Ali Hooshyari, New Zealand
MP-03.17 Patient Awareness, Diagnosis and Treatment of Bladder Cancer: Survey Results From 45 Countries
Lydia Makaroff, Belgium
MP-03.18 Robotic-Assisted Radical Cystectomy: the Use of Early Post-Operative Crp as a Predictor for Development of Ileus
Azka Yousaf, United Kingdom
MP-03.19 Snapshot Analysis From a Global Survey on the Use of Enhanced Imaging Methods in Transurethral Resection of Bladder Tumor (TURBT) in Non-Muscle-Invasive Bladder Cancer (NMIBC) Patients
Fatima Bekiroglu, Türkiye
MP-03.20 The Efficacy of 5- Ala-Induced Fluorescent Urine Cytology and Genomic Vpac Receptors Positivity in the Diagnosis of Bladder Cancer
Shreyas Rai, India
MP-03.21 Use of in Vivo Raman Spectroscopy and Cryoablation for Diagnosis and Treatment of Bladder Cancer
Yufei Liu, China
MP-03.22 Investigating Gender Preferances in Urological Care for Non Muscle Invasive Bladder Cancer (NMIBC) : a Matched-Control Analysis From an International Survey of Urologists
Aleyna Aydin, Türkiye
MP-03.23 Penetration of (Inter)national Guidelines on Non-Muscle Invasive Bladder Cancer (NMIBC): Outcome From From a Global Survey Amongst 3500 Participants
Amin Abdulmajeed, Türkiye
|
|
1545-1715
|
|
National Society Delegates Meeting
Room: Topkapi B
|
|
1545-1715
|
|
SL-02: Semi-Live Surgery interactive Session - Robotics
Room: Rumeli LL4
Chair: Jean de la Rosette, Türkiye
Moderators: Nicolae Crisan, Romania / Masatoshi Eto, Japan / Vincenzo Ficarra, Italy
|
|
|
|
1545-1715
|
|
TIPS-03: SIU Tips and Tricks Pt 3: uCare - Novel Technologies in Urology
Room: Rumeli LL12
Chair: Ranan Dasgupta, United Kingdom
Co-Chair: Mihir Desai, United States
|
|
|
|
1545-1745
|
|
WS-02: Workshop: Laparoscopy for Beginners
Room: Rumeli LL6
Co-Chair: Bhavan Rai, United Kingdom
Faculty: Zeeshan Aslam, United Kingdom / Rahul Gupta, India / K V Sanjeevan, India / Rajan Veeratterapillay, United Kingdom
|
|
Programme Description:
In this practical workshop, participants will use the laparoscopic trainer to become familiar with laparoscopic equipment. Over this 120-minute session, participants will take part in hands-on training sessions of increasing difficulty and complexity to develop the basic motor skills required for laparoscopic surgery.
Learning Objectives:
At the end of this session, the participants should be able to:
- Identify constituents of a laparoscopic stack.
- Name commonly used laparoscopic instruments.
- Carry out basic laparoscopic exercises using a Laparoscopic Trainer.
|
|
1545-1550
|
|
Introductions
Bhavan Rai, United Kingdom
|
|
1550-1605
|
|
Equipment
|
|
1600-1620
|
|
Task-1: Peg-Transfer
|
|
1620-1640
|
|
Task-2: Cutting the Circle
|
|
1640-1715
|
|
Task-3: Needle Driving
|
|
1715-1745
|
|
Task-4: Suturing
|
|
1740-1745
|
|
Feedback
|
|
Session will be presented on the SIU@U App included with your congress registration.
